Risk of Rare, Serious Genital Infection from some Diabetes DrugsAschenbrenner, Diane S. MS, RNAJN The American Journal of Nursing: December 2018 - Volume 118 - Issue 12 - p 23 doi: 10.1097/01.NAJ.0000549687.43759.a5 Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics Sodium–glucose cotransporter-2 (SGLT2) inhibitors, used to treat type 2 diabetes, now carry a warning regarding the risk of necrotizing fasciitis of the perineum. NPs should assess for this rare genital infection if a patient taking an SGLT2 inhibitor presents with redness, swelling, and pain in the genitals or in the area from the genitals to the rectum, and has a fever above 100.4°F or general malaise. Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: firstname.lastname@example.org. Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.